NCT06405737View on ClinicalTrials.gov

Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 7, 2024

Primary Completion Date

June 12, 2024

Study Completion Date

June 20, 2024

Conditions
Healthy
Interventions
DRUG

Intranasal oxytocin

Subject assigned to receive intranasal administration of oxytocin (24 IU).

DRUG

Intranasal placebo

Subjects assigned to receive intranasal administration of placebo (24 IU).

Trial Locations (1)

611731

University of Electronic Science and Technology of China (UESTC), Chengdu

All Listed Sponsors
lead

University of Electronic Science and Technology of China

OTHER

NCT06405737 - Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity | Biotech Hunter | Biotech Hunter